COMPARISON OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CANCER – RESULTS FROM A PROPENSITY-SCORE MATCHED MULTI-CENTER PATIENT COHORT

Maximilian Pallauf; Markus von Deimling; Ekaterina Laukhtina; Tatsushi Kawada; Surena F Matin; Stephen A Boorjian; Aaron M Potretzke; Siamak Daneshmand; Hooman Djaladat; Alireza Ghoreifi; Francesco Soria; Paolo Gontero; Eiji Kikuchi; Nozomi Hayakawa; Kazutoshi Fujita; John P Sfakianos; Guillaume Ploussard; Mathieu Roumiguié; Alessandro Antonelli; Morgan Rouprêt; Zine-Eddine Khene; Andrea Mari; Riccardo Campi; Alberto Breda; Axel Heidenreich; Joost L Boormans; Jay D Raman; Firas Abdollah; Nico C Grossmann; Michael Rink; Pierre I Karakiewicz; Mohammad Abufaraj; Marek Babjuk; Nirmish Singla; Shahrokh F Shariat; Benjamin Pradere

COMPARISON OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CANCER – RESULTS FROM A PROPENSITY-SCORE MATCHED MULTI-CENTER PATIENT COHORT

Maximilian Pallauf (First author)
, Markus von Deimling
, Ekaterina Laukhtina
, Tatsushi Kawada
, Surena F Matin
, Stephen A Boorjian
, Aaron M Potretzke
, Siamak Daneshmand
, Hooman Djaladat
, Alireza Ghoreifi
, Francesco Soria
, Paolo Gontero
, Eiji Kikuchi
, Nozomi Hayakawa
, Kazutoshi Fujita
, John P Sfakianos
, Guillaume Ploussard
, Mathieu Roumiguié
, Alessandro Antonelli
, Morgan Rouprêt

Zine-Eddine Khene, Andrea Mari, Riccardo Campi, Alberto Breda, Axel Heidenreich, Joost L Boormans, Jay D Raman, Firas Abdollah, Nico C Grossmann, Michael Rink, Pierre I Karakiewicz, Mohammad Abufaraj, Marek Babjuk, Nirmish Singla, Shahrokh F Shariat, Benjamin Pradere

Department of Urology and Andrology

Research output: Contribution to conference › Abstract › peer-review

Original language	American English
Publication status	Published - 2022
Event	23rd Annual Meeting of the Society of Urologic Oncology - San Diego, CA, United States Duration: 30 Nov 2022 → 2 Dec 2022

Conference with scientific content

Conference with scientific content	23rd Annual Meeting of the Society of Urologic Oncology
Country/Territory	United States
City	San Diego, CA
Period	30/11/22 → 2/12/22

Cite this

Pallauf, M., von Deimling, M., Laukhtina, E., Kawada, T., Matin, S. F., Boorjian, S. A., Potretzke, A. M., Daneshmand, S., Djaladat, H., Ghoreifi, A., Soria, F., Gontero, P., Kikuchi, E., Hayakawa, N., Fujita, K., Sfakianos, J. P., Ploussard, G., Roumiguié, M., Antonelli, A., ... Pradere, B. (2022). COMPARISON OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CANCER – RESULTS FROM A PROPENSITY-SCORE MATCHED MULTI-CENTER PATIENT COHORT. Abstract from 23rd Annual Meeting of the Society of Urologic Oncology, San Diego, CA, United States.

@conference{35d2fa2138d94613b26961807708bb24,

title = "COMPARISON OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CANCER – RESULTS FROM A PROPENSITY-SCORE MATCHED MULTI-CENTER PATIENT COHORT",

author = "Maximilian Pallauf and \{von Deimling\}, Markus and Ekaterina Laukhtina and Tatsushi Kawada and Matin, \{Surena F\} and Boorjian, \{Stephen A\} and Potretzke, \{Aaron M\} and Siamak Daneshmand and Hooman Djaladat and Alireza Ghoreifi and Francesco Soria and Paolo Gontero and Eiji Kikuchi and Nozomi Hayakawa and Kazutoshi Fujita and Sfakianos, \{John P\} and Guillaume Ploussard and Mathieu Roumigui{\'e} and Alessandro Antonelli and Morgan Roupr{\^e}t and Zine-Eddine Khene and Andrea Mari and Riccardo Campi and Alberto Breda and Axel Heidenreich and Boormans, \{Joost L\} and Raman, \{Jay D\} and Firas Abdollah and Grossmann, \{Nico C\} and Michael Rink and Karakiewicz, \{Pierre I\} and Mohammad Abufaraj and Marek Babjuk and Nirmish Singla and Shariat, \{Shahrokh F\} and Benjamin Pradere",

year = "2022",

language = "American English",

note = "23rd Annual Meeting of the Society of Urologic Oncology ; Conference date: 30-11-2022 Through 02-12-2022",

}

Pallauf, M, von Deimling, M, Laukhtina, E, Kawada, T, Matin, SF, Boorjian, SA, Potretzke, AM, Daneshmand, S, Djaladat, H, Ghoreifi, A, Soria, F, Gontero, P, Kikuchi, E, Hayakawa, N, Fujita, K, Sfakianos, JP, Ploussard, G, Roumiguié, M, Antonelli, A, Rouprêt, M, Khene, Z-E, Mari, A, Campi, R, Breda, A, Heidenreich, A, Boormans, JL, Raman, JD, Abdollah, F, Grossmann, NC, Rink, M, Karakiewicz, PI, Abufaraj, M, Babjuk, M, Singla, N, Shariat, SF & Pradere, B 2022, 'COMPARISON OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CANCER – RESULTS FROM A PROPENSITY-SCORE MATCHED MULTI-CENTER PATIENT COHORT', 23rd Annual Meeting of the Society of Urologic Oncology, San Diego, CA, United States, 30/11/22 - 2/12/22.

COMPARISON OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CANCER – RESULTS FROM A PROPENSITY-SCORE MATCHED MULTI-CENTER PATIENT COHORT. / Pallauf, Maximilian (First author); von Deimling, Markus; Laukhtina, Ekaterina et al.
2022. Abstract from 23rd Annual Meeting of the Society of Urologic Oncology, San Diego, CA, United States.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - COMPARISON OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CANCER – RESULTS FROM A PROPENSITY-SCORE MATCHED MULTI-CENTER PATIENT COHORT

AU - Pallauf, Maximilian

AU - von Deimling, Markus

AU - Laukhtina, Ekaterina

AU - Kawada, Tatsushi

AU - Matin, Surena F

AU - Boorjian, Stephen A

AU - Potretzke, Aaron M

AU - Daneshmand, Siamak

AU - Djaladat, Hooman

AU - Ghoreifi, Alireza

AU - Soria, Francesco

AU - Gontero, Paolo

AU - Kikuchi, Eiji

AU - Hayakawa, Nozomi

AU - Fujita, Kazutoshi

AU - Sfakianos, John P

AU - Ploussard, Guillaume

AU - Roumiguié, Mathieu

AU - Antonelli, Alessandro

AU - Rouprêt, Morgan

AU - Khene, Zine-Eddine

AU - Mari, Andrea

AU - Campi, Riccardo

AU - Breda, Alberto

AU - Heidenreich, Axel

AU - Boormans, Joost L

AU - Raman, Jay D

AU - Abdollah, Firas

AU - Grossmann, Nico C

AU - Rink, Michael

AU - Karakiewicz, Pierre I

AU - Abufaraj, Mohammad

AU - Babjuk, Marek

AU - Singla, Nirmish

AU - Shariat, Shahrokh F

AU - Pradere, Benjamin

PY - 2022

Y1 - 2022

M3 - Abstrakt

T2 - 23rd Annual Meeting of the Society of Urologic Oncology

Y2 - 30 November 2022 through 2 December 2022

ER -